COVID-19 vaccines are on track to become the most thoroughly tested vaccines in human history for any disease.
Over 200,000 Americans safely took part in trials, and more than twice that many people were tested world-wide.
After a history of failing to adequately include all racial and ethnic minorities in trials, the COVID vaccines are the first to prioritize and achieve samples that fully reflected the American public.
The COVID vaccine trials also made a point of testing Americans of different ages and including people with other health problems that make them more vulnerable to COVID.
Studies found the COVID vaccine works as well in racial and ethnic minorities as in white Americans. No Person of Color who received the vaccine later contracted COVID.
Most trial participants had soreness in their arm like with the flu vaccine and other vaccines. Some had soreness and body aches that lasted longer than a day.
People of different races and ethnicities were no more or less likely to experience side-effects of the vaccine. Older Americans were slightly less likely to report side-effects.
Vaccine Testing Phases
Who Makes It?
- After extensive testing, three COVID-19 vaccinations have been approved by the FDA for public use: Moderna, Johnson & Johnson and Pfizer/BioNTech.
Moderna, Johnson & Johnson and Pfizer are U.S. companies.
Who Takes It?
165,718,717 Americans have been vaccinated
1,780,214,473 doses have been given worldwide.
America has the highest vaccination rate of any country with a population over 10 million
1,618,194 doses are given to Americans each day
All American adults are now eligible to get vaccinated
To learn more about the minds and science behind the vaccine, visit the bios of our COVID vaccine experts.
NIH COVID Vaccine Program
NIH Infectious Disease Program
To request more information about COVID-19 and FLU vaccines, please fill out this form.
By submitting this form, you agree to receive text messages for purposes related to vaccine information only. Message and data rates may apply.